Drew Moghanaki: IMRT with MR-linac and VMAT for lung SABR

Drew Moghanaki shared a post on X about a paper by Jong Min Park et al. published in Radiation Oncology.

“Comparison of treatment plans between IMRT with MR-linac and VMAT for lung SABR”

Authors: Jong Min Park, Hong-Gyun Wu, Hak Jae Kim, Chang Heon Choi and Jung-in Kim.

“Here are the results of a dosimetric study published in 2019 demonstrating how MRIdian-based lung SBRT can reduce incidental doses delivered to the heart (green) and esophagus (orange).”

Source: Drew Moghanaki/X

More posts featuring Drew Moghanaki.

Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).